1887

Abstract

is a common nosocomial pathogen transmitted mainly via its spores. These spores can remain viable on contaminated surfaces for several months and are resistant to most commonly used cleaning agents. Thus, effective decontamination of the environment is essential in preventing the transmission of in health-care establishments. However, this emphasis on decontamination must also be extended to laboratories due to risk of exposure of staff to potentially virulent strains. Though few cases of laboratory-acquired infection have been reported, the threat of infection by in the laboratory is real. Our aim was to test the efficacy of four disinfectants, Actichlor, MicroSol 3+, TriGene Advance and Virkon, and one laboratory decontaminant, Decon 90, against vegetative cells and spores of . Five strains were selected for the study: the three most commonly encountered epidemic strains in Scotland, PCR ribotypes 106, 001 and 027, and control strains 630 and VPI 10463. MICs were determined by agar dilution and broth microdilution. All the agents tested inhibited the growth of vegetative cells of the selected strains at concentrations below the recommended working concentrations. Additionally, their effect on spores was determined by exposing the spores of these strains to different concentrations of the agents for different periods of time. For some of the agents, an exposure of 10 min was required for sporicidal activity. Further, only Actichlor was able to bring about a 3 log reduction in spore numbers under clean and dirty conditions. It was also the only agent that decontaminated different hard, non-porous surfaces artificially contaminated with spores. However, this too required an exposure time of more than 2 min and up to 10 min. In conclusion, only the chlorine-releasing agent Actichlor was found to be suitable for the elimination of spores from the environment, making it the agent of choice for the decontamination of laboratory surfaces.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.030288-0
2011-08-01
2019-10-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/8/1218.html?itemId=/content/journal/jmm/10.1099/jmm.0.030288-0&mimeType=html&fmt=ahah

References

  1. Arfons L. , Ray A. J. , Donskey C. J. . ( 2005; ). Clostridium difficile infection among health care workers receiving antibiotic therapy. . Clin Infect Dis 40:, 1384–1385. [CrossRef].[PubMed]
    [Google Scholar]
  2. Bartlett J. G. . ( 2008; ). Historical perspectives on studies of Clostridium difficile and C. difficile infection. . Clin Infect Dis 46: Suppl. 1 S4–S11. [CrossRef].[PubMed]
    [Google Scholar]
  3. Bartlett J. G. , Moon N. , Chang T. W. , Taylor N. , Onderdonk A. B. . ( 1978; ). Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. . Gastroenterology 75:, 778–782.[PubMed]
    [Google Scholar]
  4. Block C. . ( 2004; ). The effect of Perasafe and sodium dichloroisocyanurate (NaDCC) against spores of Clostridium difficile and Bacillus atrophaeus on stainless steel and polyvinyl chloride surfaces. . J Hosp Infect 57:, 144–148. [CrossRef].[PubMed]
    [Google Scholar]
  5. Bouza E. , Martin A. , Van den Berg R. J. , Kuijper E. J. . ( 2008; ). Laboratory-acquired Clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers?. Clin Infect Dis 47:, 1493–1494. [CrossRef].[PubMed]
    [Google Scholar]
  6. Brown R. , Collee J. G. , Poxton I. R. . ( 1996; ). Bacteroides, Fusobacterium and other Gram-negative anaerobic rods; anaerobic cocci; identification of anaerobes. . In Mackie and McCartney Practical Medical Microbiology, pp. 501–519. Edited by Collee J. G. , Fraser A. G. , Marmion B. P. , Simmons A. . . London:: Churchill Livingstone;.
    [Google Scholar]
  7. Fawley W. N. , Wilcox M. H. . ( 2001; ). Molecular epidemiology of endemic Clostridium difficile infection. . Epidemiol Infect 126:, 343–350. [CrossRef].[PubMed]
    [Google Scholar]
  8. Fawley W. N. , Underwood S. , Freeman J. , Baines S. D. , Saxton K. , Stephenson K. , Owens R. C. Jr , Wilcox M. H. . ( 2007; ). Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. . Infect Control Hosp Epidemiol 28:, 920–925. [CrossRef].[PubMed]
    [Google Scholar]
  9. Fekety R. , Kim K. H. , Brown D. , Batts D. H. , Cudmore M. , Silva J. Jr . ( 1981; ). Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. . Am J Med 70:, 906–908. [CrossRef].[PubMed]
    [Google Scholar]
  10. Fraise A. . ( 2011; ). Currently available sporicides for use in healthcare, and their limitations. . J Hosp Infect 77:, 210–212. [CrossRef].[PubMed]
    [Google Scholar]
  11. Freeman J. , Bauer M. P. , Baines S. D. , Corver J. , Fawley W. N. , Goorhuis B. , Kuijper E. J. , Wilcox M. H. . ( 2010; ). The changing epidemiology of Clostridium difficile infections. . Clin Microbiol Rev 23:, 529–549. [CrossRef].[PubMed]
    [Google Scholar]
  12. George R. H. , Symonds J. M. , Dimock F. , Brown J. D. , Arabi Y. , Shinagawa N. , Keighley M. R. , Alexander-Williams J. , Burdon D. W. . ( 1978; ). Identification of Clostridium difficile as a cause of pseudomembranous colitis. . BMJ 1:, 695. [CrossRef].[PubMed]
    [Google Scholar]
  13. Gerding D. N. , Johnson S. , Peterson L. R. , Mulligan M. E. , Silva J. Jr . ( 1995; ). Clostridium difficile-associated diarrhea and colitis. . Infect Control Hosp Epidemiol 16:, 459–477. [CrossRef].[PubMed]
    [Google Scholar]
  14. Hell M. , Indra A. , Huhulescu S. , Allerberger F. . ( 2009; ). Clostridium difficile infection in a health care worker. . Clin Infect Dis 48:, 1329. [CrossRef].[PubMed]
    [Google Scholar]
  15. Kim K. H. , Fekety R. , Batts D. H. , Brown D. , Cudmore M. , Silva J. Jr , Waters D. . ( 1981; ). Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. . J Infect Dis 143:, 42–50. [CrossRef].[PubMed]
    [Google Scholar]
  16. Lawley T. D. , Clare S. , Deakin L. J. , Goulding D. , Yen J. L. , Raisen C. , Brandt C. , Lovell J. , Cooke F. et al. ( 2010; ). Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. . Appl Environ Microbiol 76:, 6895–6900. [CrossRef].[PubMed]
    [Google Scholar]
  17. Lyerly D. M. , Krivan H. C. , Wilkins T. D. . ( 1988; ). Clostridium difficile: its disease and toxins. . Clin Microbiol Rev 1:, 1–18.[PubMed]
    [Google Scholar]
  18. McFarland L. V. , Stamm W. E. . ( 1986; ). Review of Clostridium difficile-associated diseases. . Am J Infect Control 14:, 99–109. [CrossRef].[PubMed]
    [Google Scholar]
  19. McFarland L. V. , Mulligan M. E. , Kwok R. Y. , Stamm W. E. . ( 1989; ). Nosocomial acquisition of Clostridium difficile infection. . N Engl J Med 320:, 204–210. [CrossRef].[PubMed]
    [Google Scholar]
  20. NCCLS ( 2004; ). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, Approved Standard, 6th edn. NCCLS document M11-A6. Wayne, PA:: National Committee for Clinical Laboratory Standards;.
    [Google Scholar]
  21. Ray A. J. , Donskey C. J. . ( 2003; ). Clostridium difficile infection and concurrent vancomycin-resistant Enterococcus stool colonization in a health care worker: case report and review of the literature. . Am J Infect Control 31:, 54–56. [CrossRef].[PubMed]
    [Google Scholar]
  22. Samore M. H. , Venkataraman L. , DeGirolami P. C. , Arbeit R. D. , Karchmer A. W. . ( 1996; ). Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. . Am J Med 100:, 32–40. [CrossRef].[PubMed]
    [Google Scholar]
  23. Ungurs M. , Wand M. , Vassey M. , O’Brien S. , Dixon D. , Walker J. , Sutton J. M. . ( 2011; ). The effectiveness of sodium dichloroisocyanurate treatments against Clostridium difficile spores contaminating stainless steel. . Am J Infect Control 39:, 199–205. [CrossRef].[PubMed]
    [Google Scholar]
  24. Weber D. J. , Rutala W. A. , Miller M. B. , Huslage K. , Sickbert-Bennett E. . ( 2010; ). Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. . Am J Infect Control 38: Suppl 1 S25–S33. [CrossRef].[PubMed]
    [Google Scholar]
  25. Wheeldon L. J. , Worthington T. , Hilton A. C. , Lambert P. A. , Elliott T. S. J. . ( 2008; ). Sporicidal activity of two disinfectants against Clostridium difficile spores. . Br J Nurs 17:, 316–320.[PubMed] [CrossRef]
    [Google Scholar]
  26. Wilcox M. H. , Fawley W. N. , Wigglesworth N. , Parnell P. , Verity P. , Freeman J. . ( 2003; ). Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. . J Hosp Infect 54:, 109–114. [CrossRef].[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.030288-0
Loading
/content/journal/jmm/10.1099/jmm.0.030288-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error